secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001493152-24-020883
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa enters ATM equity agreement to sell up to $2.4M in common stock
------------------------------------------------------------------------

- Sales agreement with A.G.P./Alliance Global Partners for at-the-market offering of up to $2.4 million.
- Sales Agent receives up to 3% commission on gross proceeds from shares sold.
- Net proceeds to fund R&D for oncology drug candidates and working capital.
- Registration statement filed on May 21, 2024 but not yet effective.
- Company is not obligated to sell any shares under the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224020883/0001493152-24-020883-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224020883/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020883

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer